We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Top Sells

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$39.1M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$31.2M
3
XEC
CIMAREX ENERGY CO
XEC
+$23.4M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$21.9M
5
SBNY
Signature Bank
SBNY
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRU icon
2901
Spruce Power Holding Corp
SPRU
$39.9M
$137K ﹤0.01%
5,187
-199
-4% -$7.69K
STKS icon
2902
The ONE Group
STKS
$53M
$136K ﹤0.01%
10,789
-316
-3% -$4.17K
RAIN
2903
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$136K ﹤0.01%
+10,594
New +$151K
HLTH
2904
DELISTED
Cue Health Inc. Common Stock
HLTH
$134K ﹤0.01%
+10,021
New +$110K
MBIO icon
2905
Mustang Bio
MBIO
$4.55M
$133K ﹤0.01%
107
+5
+5% +$8.07K
NBEV
2906
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$130K ﹤0.01%
126,539
+5,029
+4% +$6.64K
TNXP icon
2907
Tonix Pharmaceuticals
TNXP
$192M
$129K ﹤0.01%
1
– –
VIRX
2908
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$128K ﹤0.01%
35,196
-780
-2% -$4.16K
ACIC icon
2909
American Coastal Insurance
ACIC
$493M
$127K ﹤0.01%
29,180
-1,186
-4% -$5.09K
PBFS icon
2910
Pioneer Bancorp
PBFS
$434M
$126K ﹤0.01%
11,158
+168
+2% +$2.08K
MTEM
2911
DELISTED
Molecular Templates, Inc.
MTEM
$126K ﹤0.01%
2,137
-30
-1% -$2.25K
IMDX
2912
Insight Molecular Diagnostics
IMDX
$156M
$125K ﹤0.01%
2,875
-274
-9% -$15.8K
ONCT
2913
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$125K ﹤0.01%
2,750
-14
-0.5% -$942
CSPR
2914
DELISTED
Casper Sleep Inc.
CSPR
$123K ﹤0.01%
18,446
+100
+0.5% +$535
VRCA icon
2915
Verrica Pharmaceuticals
VRCA
$87.3M
$122K ﹤0.01%
1,335
+37
+3% +$4.19K
AWH
2916
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$119K ﹤0.01%
4,479
-48
-1% -$1.82K
PBYI icon
2917
Puma Biotechnology
PBYI
$454M
$118K ﹤0.01%
38,771
-838
-2% -$3.64K
WVE icon
2918
Wave Life Sciences
WVE
$1.2B
$118K ﹤0.01%
37,683
+633
+2% +$2.63K
REV
2919
DELISTED
Revlon, Inc.
REV
$118K ﹤0.01%
10,446
-216
-2% -$2.51K
ONCR
2920
DELISTED
Oncorus, Inc.
ONCR
$117K ﹤0.01%
22,191
-551
-2% -$4.27K
CDZI icon
2921
Cadiz
CDZI
$291M
$116K ﹤0.01%
30,165
-1,564
-5% -$8.46K
AQB icon
2922
AquaBounty Technologies
AQB
$6.02M
$115K ﹤0.01%
2,729
-94
-3% -$6.05K
PSEC icon
2923
Prospect Capital
PSEC
$1.17B
$114K ﹤0.01%
13,555
+14
+0.1% +$118
CARM
2924
DELISTED
Carisma Therapeutics
CARM
$113K ﹤0.01%
6,951
-171
-2% -$3.44K
CRD.A icon
2925
Crawford & Co Class A
CRD.A
$669M
$113K ﹤0.01%
15,067
-677
-4% -$5.59K
115 116
117
118 119

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.